Apellis Pharmaceuticals, Inc. Analytics - Traffic, Statistics and Competitor Tracking


Apellis Pharmaceuticals, Inc. Website Screenshot

http://www.apellis.com

Apellis Pharmaceuticals, Inc. Company Intro

Apellis is a global biopharmaceutical company that develops life-changing therapies. By pioneering targeted C3 therapies, we aim to treat diseases that are driven by excessive activation of the complement cascade, including those within hematology, ophthalmology, and nephrology.

Industry

Healthcare

Apellis Pharmaceuticals, Inc. Headquaters

6400 Westwind Way
Crestwood,40014
United States


Apellis Pharmaceuticals, Inc. Share price

14 May 2021 01:07 GMT

$46.13

-0.51 (-1.09 %)


Apellis Pharmaceuticals, Inc. Market cap

$3.75 B


WMC RANKING

2021

Apellis Pharmaceuticals, Inc. # 334

Biotechnology

Latest Apellis Pharmaceuticals, Inc. News

News 14 May 2021

$APLS FDA Approves Empaveli Injection For Adults With ...

Apellis Pharmaceuticals Inc. NASDAQ:APLS. 44.25. -1.39 (-3.05%). 5:00:22 PM EDT: $47.50 +3.25 (+7.35%). Twitter Share. Products ...

News 15 May 2021

FDA Approves Pegcetacoplan for Paroxysmal Nocturnal ...

... (FDA) approval of EMPAVELI (pegcetacoplan) for adults with paroxysmal nocturnal hemoglobinuria (PNH). News release. Apellis Pharmaceuticals, Inc. May ...

News 15 May 2021

Apellis Announces US Food and Drug Administration (FDA ...

WALTHAM, MA, USA I May 14, 2021 I Apellis Pharmaceuticals, Inc. (Nasdaq: APLS), a global biopharmaceutical company and leader in targeted C3 therapies, ...


WMC Market Score


WMC Market to Revenue Score


Apellis Pharmaceuticals, Inc. Market Financials


Revenue, Expenses, Profit


Company Currency Revenue Expense Profit Market Cap WMC Sector Score
Apellis Pharmaceuticals, Inc. USD $0 $338,150 $-422,955 $37,500B 334
Regeneron Pharmaceuticals, Inc. USD $9,243,500 $5,152,600 $3,156,000 $540,220B 1
Vertex Pharmaceuticals Incorporated USD $6,205,683 $2,599,993 $2,711,647 $550,560B 2
Alexion Pharmaceuticals, Inc. USD $6,069,900 $2,656,500 $603,400 $380,130B 3
Incyte Corporation USD $2,229,409 $1,622,822 $446,906 $181,110B 4

Market Analytics


Company Search vs Top 4 Industry Competitors



Total Apellis Pharmaceuticals, Inc. Social Followers vs Top 4 Industry Competitors



Apellis Pharmaceuticals, Inc. Post vs Top 4 Industry Competitors




Apellis Pharmaceuticals, Inc. Digital Footprint By Size vs Top 4 Industry Competitors



Apellis Pharmaceuticals, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors



Apellis Pharmaceuticals, Inc. WMC Market Score Calculations


Details Revenue Total Social Followers Total Social Posts Search Volume Digital Footprint Size Digital change (New Pages) WMC Market Score
Apellis Pharmaceuticals, Inc. 0 9.80 0.05 0 0 0 3.79
Regeneron Pharmaceuticals, Inc. 100 23.93 2.37 100 0 0 48.56
Vertex Pharmaceuticals Incorporated 67.14 34.98 0.75 86 0 0 46.73
Alexion Pharmaceuticals, Inc. 65.67 100 100 60 0 0 100
Incyte Corporation 24.12 4.93 0.05 2 0 0 2.85

Book a demo

Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.

* required fields

You'll learn how to:

  • 1. Automatically monitor your entire digital landscape including competitors
  • 2. View all new industry activity in real time
  • 3. Monitor your position in your industry
  • 4. Enrich your reports and strategy
  • 5. Empower your teams with knowledge

Our platform is loved & trusted by avariety
of world-leading brands

  • unilever
  • wavesight
  • acca
  • abeerdeen
  • UK2
  • umbo
  • rb
Industries